70 years of Achievements.jpg

China Daily

News> Business> Content
Thursday, May 16, 2019, 10:29
China takes multiple measures to improve business environment
By Xinhua
Thursday, May 16, 2019, 10:29 By Xinhua

Zhang Mao (center), minister of the State Administration for Market Regulation, attends a press conference on strengthening market regulation and safeguarding market order for the second session of the 13th National People's Congress (NPC) in Beijing, March 11, 2019. (FENG YONGBIN / CHINADAILY.COM.CN)

BEIJING — China's market regulator has taken multiple measures in the past year to create a level playing field for all market competitors, an official said Wednesday.

Tighter supervision across the whole production chain has been carried out to reform the country's vaccine management system

Gan Lin, Deputy chief with the State Administration for Market Regulation

ALSO READ: Nation vows to step up market access

China has become more business-friendly, with the average time for starting a business in the country shortened from 20 days to 8.5 days in 2018, Gan Lin, deputy chief with the State Administration for Market Regulation told a press conference on a report highlighting China's new progress on intellectual property protection and business environment.

Gan said the regulator emphasized anti-monology enforcement last year in pursuing a better business environment, which strictly punished monopoly pricing in areas concerning people's livelihood.

Some key sectors such as electricity and real estate faced stricter pricing supervision, with 18,000 infringement cases investigated. In addition, 11,000 cases involving unfair competition were cracked.

READ MORE: Li calls for spurring market entities

Gan said the regulator also took efforts to optimize the consumption environment, and one of the measures is tightening the supervision on vaccine and drug production.

"Tighter supervision across the whole production chain has been carried out to reform the country's vaccine management system, and on-site inspection of high-risk products such as blood products and injections has also been conducted," Gan said.


Share this story

CHINA DAILY
HONG KONG NEWS
OPEN
Please click in the upper right corner to open it in your browser !